The University of Chicago Header Logo

Connection

Walter M. Stadler to Pteridines

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Pteridines.
Walter M. Stadler
Connection Strength
0.464
Pteridines
  1. An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer. Cancer. 2014 Apr 01; 120(7):976-82.
    View in: PubMed
    Score: 0.464
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.